Dergiler / Marmara Medical Journal / 2021 / Cilt: 34 - Sayı: 2

Mature cystic ovarian teratomas: Relationship between histopathological contents and clinical features

Sayfa
167–174
Yayın Tarihi
2021-05-31
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

LDH and CA 19-9 can be a helpful tool in predicting mature cystic teratomas.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Objectives: Mature cystic teratomas (MCT) originate from three germ layers: ectoderm, mesoderm and endoderm.
📊
Temel Bulgular & Veri:Materials and Methods: The data of 106 patients who were operated for ovarian MCT between 2015 and 2020 were analyzed retrospectively.
💡
Sonuç & Katkı:LDH and CA 19-9 can be a helpful tool in predicting mature cystic teratomas.
🔬Tür:Araştırma Makalesi
📍Kapsam:2015 Verileri
⚙️Değişkenler:Mature cystic teratoma · Germ layers · Tumor markers

Abstract

Objectives: Mature cystic teratomas (MCT) originate from three germ layers: ectoderm, mesoderm and endoderm. The predictive significance of tumor markers in mature cystic teratomas is still unclear. In this study, we aimed to evaluate the predictive value of tumor markers in ovarian MCTs and histopathological contents of tumor. Materials and Methods: The data of 106 patients who were operated for ovarian MCT between 2015 and 2020 were analyzed retrospectively. In addition, slides in the pathology archive were re-examined under a microscope to evaluate their histopathological contents. Results: The average age of the patients was 35.7; 26.7 in the cystectomy group and 42.1 in the oophorectomy group (p = 0.000). The ratio of tumor markers exceeding the cut off value for carbohydrate antigen (CA 19-9), lactate dehydrogenase (LDH), cancer antigen (CA 125), carcinoma antigen (CA 15-3), carcinoembryonic antigen (CEA) were 45.2%; 47.7%; 8.15%; 12.3%; 6.9%, respectively. Histopathological examination of MCTs revealed 99.1% ectoderm, 45.3% mesodermal, 39.6% endodermal origin. Conclusion: Mature cystic teratoma is a benign tumor of the reproductive age that contains three germ layers in various proportions. LDH and CA 19-9 can be a helpful tool in predicting mature cystic teratomas.

🔖

Bu Makaleye Atıf Yap

ATIGAN, A., KARAKAYA, Y. A., CABUS, U. (2021). Mature cystic ovarian teratomas: Relationship between histopathological contents and clinical features. Marmara Medical Journal, Cilt: 34 - Sayı: 2, 167–174. https://ajindex.com/articles/688318

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (7)

  1. Tewari K, Cappuccini F, Disaia PJ, Berman ML, Manetta A, Kohler MF. Malignant germ cell tumors of the ovary. Obstet Gynecol 2000;95:128‐33. doi:10.1016/s0029-7844(99)00470-6
  2. Zalel Y, Piura B, Elchalal U, Czernobilsky B, Antebi S, Dgani R. Diagnosis and management of malignant germ cell ovarian tumors in young females. Int J Gynaecol Obstet 1996;55:1- 10. doi: HYPERLINK “https://doi.org/10.1016/0020- 7292(96)02719-1” \t “_blank” 10.1016/0020-7292(96)02719-1
  3. Mohanty MK, Sahu P, Jaiswal AA, et al. A huge immature cervical teratoma, antenatal diagnosis, and its management – an unusual entity. J Clin Neonatol 2013;2:42‐5. doi:10.4103/2249- 4847.109249 Peterson CM, Buckley C, Holley S, Menias CO. Teratomas: a multimodality review. Curr Probl Diagn Radiol 2012;41:210-19. doi: HYPERLINK “https://doi.org/10.1067/j. cpradiol.2012.02.001” 10.1067/j.cpradiol.2012.02.001 Maharjan S. Mature cystic teratoma of ovary with squamous cell carcinoma arising from it. Clin Case Rep 2019;7:668-71. doi: 10.1002/ccr3.2062
  4. Comerci JT Jr, Licciardi F, Bergh PA, Gregori C, Breen JL. Mature cystic teratoma: a clinicopathologic evaluation of 517 cases and review of the literature. Obstet Gynecol 1994;84:22-8.
  5. Wang WC, Lai YC. Evidence of metachronous development of ovarian teratomas: a case report of bilateral mature cystic teratomas of the ovaries and systematic literature review. J Ovarian Res 2017;10:17. doi:10.1186/s13048.017.0313-8 Al-Salem A. Teratoma. In: An Illustrated Guide to Pediatric Surgery. Cham:Springer International Publishing, 2014;63:491-503. doi: 10.1007/978-3-319-06665-3_63. Rha SE, Byun JY, Jung SE, et al. Atypical CT and MRI manifestations of mature ovarian cystic teratomas. AJR 2004;183:743-50. doi: 10.2214/ajr.183.3.1830743 Hoo WL, Yazbek J, Holland T, Mavrelos D, Tong EN, Jurkovic D. Expectant management of ultrasonically diagnosed ovarian dermoid cysts: is it possible to predict outcome?. Ultrasound Obstet Gynecol 2010;36:235‐40. doi:10.1002/uog.7610 Ustunyurt E, Gungor T, Iskender C, Ustunyurt BO, Bilge U, Mollamahmutoglu L. Tumor markers in mature cystic teratomas of the ovary. Arch Gynecol Obstet 2009;279:145-7. doi: 10.1007/s00404.008.0688-2. Ito K. Significance of CA19-9 in mature cystic teratoma. Nihon Sanka Fujinka Gakkai Zasshi 1992;44:524-28.
  6. Mikuni M, Makinoda S, Tanaka T, Okuda T, Domon H, Fujimoto S. Evaluation of tumor marker in ovarian dermoid cyst. Nihon Sanka Fujinka Gakkai Zasshi 1990;42:479-84.
  7. Var T, Tonguc EA, Ugur M, Altinbas S, Tokmak A.